Welcome to our dedicated page for Kkr & Co SEC filings (Ticker: KKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The KKR & Co. Inc. (NYSE: KKR) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents. As a global investment firm offering alternative asset management, capital markets and insurance solutions, KKR uses SEC filings to report material events, financing activities, governance changes and financial results.
Recent 8-K filings illustrate the range of topics covered. For example, KKR has filed current reports describing earnings releases for specific quarters, the completion of an offering of 5.100% Senior Notes due 2035 and related indenture terms, and changes in its Board of Directors and Board committees. Other 8-Ks disclose matters such as the posting of investor presentations for KKR and its insurance subsidiary group, Global Atlantic Financial Group, and changes in certain officer roles.
Through this page, users can review filings that relate to KKR’s common stock, preferred stock and various notes, as referenced in the cover pages of its 8-Ks. These documents help investors understand how KKR finances its operations, manages governance and communicates financial information to the market. Filings may also reference KKR’s insurance subsidiaries and Global Atlantic, indicating how insurance activities are integrated into the broader corporate structure.
Stock Titan enhances access to these filings with AI-powered tools that summarize lengthy documents and highlight key sections, helping users interpret disclosures about debt offerings, governance changes, results of operations and other reportable events. Real-time updates from EDGAR ensure that new KKR filings, including Forms 8-K and other relevant submissions, are available as they are posted, while AI summaries provide a starting point for deeper review of the underlying regulatory text.
KKR & Co. Inc. director reported an equity award in the form of 1,605 restricted stock units of KKR common stock. These units were granted on December 11, 2025 under the Amended and Restated KKR & Co. Inc. 2019 Equity Incentive Plan and will generally vest on December 1, 2026. When they vest, each unit is expected to convert into one share of KKR common stock. After this reported grant, the director beneficially owns 1,847 shares of KKR common stock in total on a direct basis.
KKR & Co. Inc. insider reports a charitable stock donation and updated holdings. A reporting person who is a director and Co-Executive Chairman of KKR reported the donation of 350,000 shares of common stock on 11/12/2025. The shares were donated by a limited partnership controlled by the insider to a charitable foundation in which the insider has no pecuniary interest, and the partnership continues to hold additional shares for future donations. Following this transaction, the insider reports beneficial ownership of 5,460,000 shares indirectly through the partnership, 73,006,022 shares directly, and additional indirect holdings of 1,549,369, 1,000,000, and 15,227 shares through other entities and the insider’s spouse. The insider states that beneficial ownership of indirectly held securities is disclaimed except to the extent of any pecuniary interest.
KKR & Co. Inc. reports Q3 2025 results showing larger scale and higher quarterly earnings across its asset management and insurance businesses. Total assets reached $398.5B, up from $360.1B at year-end 2024, while total equity increased to $73.0B.
Q3 2025 total revenues were $5.53B, up from $4.79B a year earlier, driven mainly by insurance premiums and investment income, partly offset by lower asset management capital-allocation income. Net income was $1.84B, versus $1.43B in Q3 2024.
Net income attributable to KKR & Co. Inc. rose to $900M in Q3 2025 from $601M, with diluted EPS of $0.90 versus $0.64. For the first nine months, net income attributable to KKR & Co. Inc. was $1.23B, down from $1.95B in the prior-year period.
KKR strengthened its capital base by issuing 51.75 million shares of 6.25% Series D Mandatory Convertible Preferred Stock, adding $2.54B of preferred equity. Common shares outstanding were 890.97 million as of September 30, 2025, and KKR now owns 100% of Global Atlantic after completing the remaining minority buyout on January 2, 2024.
KKR & Co. Inc. furnished an earnings release announcing financial results for the quarter and nine months ended September 30, 2025. The release is provided as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
Consistent with Form 8‑K General Instruction B.2, the information in Item 2.02 and Exhibit 99.1 is furnished, not filed, and is not incorporated by reference into Securities Act or Exchange Act filings unless specifically referenced.
KKR-affiliated entities reported an insider acquisition of 61,725.029 shares of KKR Real Estate Select Trust Inc. Class I Common Stock on 10/31/2025. The shares were issued as payment for management and/or incentive fees under the investment advisory agreement, with KKR Registered Advisor LLC directing issuance to its affiliate, KKR Alternative Assets LLC (Footnote 1). The transaction is coded J at a listed price of $23.65 per share, and the filing indicates it was made by more than one reporting person. Following the transaction, 10,954,992.199 shares were beneficially owned indirectly (Footnote 2). The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest (Footnote 3).
KKR-affiliated reporting persons filed a Form 4 for BrightSpring Health Services, Inc. (BTSG) reflecting a large secondary sale and related donations. On 10/22/2025, KKR Phoenix Aggregator L.P. sold 14,745,000 shares of BTSG common stock in an underwritten public offering at a net price of $28.782 per share.
Following the sale, beneficial ownership was 62,351,337 shares, then 61,942,032 shares after in-kind distributions of 409,305 shares for charitable donations. Separate gifts included 50,484 shares by Henry R. Kravis and 39,493 shares by George R. Roberts. The filing states ownership is held indirectly through KKR entities, and each reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
KKR & Co. Inc. reported that it has posted a new investor presentation titled “Asset-Based Finance Overview” on its website for KKR common stockholders and analysts. The presentation is available in the Investor Center section of the company’s site. KKR notes that it uses its website as a channel to share financial and other important information about the company.
Arnold Craig, a director of KKR & Co. Inc. (KKR), was granted 242 restricted stock units on 09/23/2025. The RSUs were awarded under the Amended and Restated KKR & Co. Inc. 2019 Equity Incentive Plan and carry a transaction price of $0, indicating a grant rather than a purchase. The filing reports 242 shares beneficially owned following the transaction, with ownership shown as direct. The RSUs are generally scheduled to vest on 12/01/2025 and, upon vesting, each unit will be settled by delivery of one share of KKR common stock.
The Form 4 was executed by an attorney-in-fact on 09/24/2025.
Craig Arnold filed an Initial Statement on Form 3 for KKR & Co. Inc. (KKR) reporting the event date 09/23/2025. The filing identifies Mr. Arnold as a director and indicates no securities are beneficially owned. The form is signed by an attorney-in-fact on 09/24/2025 and includes a Power of Attorney as Exhibit 24.1.
KKR & Co. Inc. reported the appointment of Craig Arnold to its Board of Directors effective September 23, 2025. The Board was increased to fifteen members by written consent of KKR Management LLP, the sole holder of the Series I preferred stock. Mr. Arnold will serve on the Audit Committee and will participate in the Company’s standard non-executive director cash and equity compensation arrangements, prorated from his appointment date. He also entered into the Company’s customary indemnification agreement for non-executive directors. The filing furnishes a press release as Exhibit 99.1 announcing the appointment; that exhibit is furnished and not filed, and the Item 7.01 disclosure is not deemed "filed" under the Exchange Act.